Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) and Amphenol Co. (NYSE: APH), Albany Molecular Research, Inc. (AMRI), Ariba, Inc. (ARBA) and Lululemon (NASDAQ: LULU), were upgraded or downgraded by analysts.
Anthera Pharmaceuticals, Inc. (ANTH) was upgraded by Wedbush from a “Neutral” rating to an “Outperform” rating. They have a price target of $8.00 on the company.
Amphenol Co. (APH) was upgraded by Macquarie from a “Neutral” rating to an “Outperform” rating.
Sterne Agee reiterated its “Buy” rating on Albany Molecular Research, Inc. (AMRI). They have a price target of $7.00 on the company.
Roth Capital upgraded shares of Ariba, Inc. (ARBA) to a “Buy” rating.
Lululemon (LULU) was upgraded by KeyBanc from an “Underweight” rating to a “Buy” rating. They have a price target of $58.00 on the company.
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/